EcoDrugPlus

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSMAMG00000005603
Gene Symbol: RPTOR
3 Cross references
213 Possible Orthologues:

Renin

Ensembl ID : ENSMAMG00000012112
Gene Symbol: REN
2 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSMAMG00000013635
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSMAMG00000001788
Gene Symbol: RARB
3 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSMAMG00000011322
Gene Symbol: LOC113136524
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma A

Ensembl ID : ENSMAMG00000007394
Gene Symbol: RARGA
2 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSMAMG00000003975
Gene Symbol: LOC113130310
3 Cross references
377 Possible Orthologues:

Retinoic Acid Receptor, Alpha B

Ensembl ID : ENSMAMG00000004959
Gene Symbol: RARAB
2 Cross references
331 Possible Orthologues:

Retinoid X Receptor, Alpha A

Ensembl ID : ENSMAMG00000003873
Gene Symbol: RXRAA
2 Cross references
225 Possible Orthologues:

Retinoid X Receptor, Beta B

Ensembl ID : ENSMAMG00000014664
Gene Symbol: RXRBB
3 Cross references
211 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSMAMG00000006313
Gene Symbol: LOC113137142
2 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSMAMG00000015455
Gene Symbol: RPL10
3 Cross references
408 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).